With univariate survival analysis, many features were associated with outcome: age, gender, no- or light vs. heavy smoking, PS, TNM substages, pathological type adenocarcinomas vs. others, sum of TNM-PS-pathology, EGFR mutations, the number of PBT cycles and TKI-TT. This evidence concerns the gene EGFR and adenocarcinoma.